Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Abivax priced an upsized $800M public offering at $125.00 per ADS, representing a 2.39% premium to the three-day VWAP. The offering size was increased from $600M due to oversubscription, with proceeds expected to extend the company's cash runway into Q2 2029.
Key figures
- Deal Value Usd
- $800.0 million
- Offering Price
- $125.00
- Shares Offered
- 6400000
- Cash runway
- Q2 2029
- Dilution base
- 8.0%
- Existing cash
- €491.6 million
- Premium to vwap
- 2.39%
- Proceeds with option
- $920.0 million
- Dilution full exercise
- 9.2%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.